In this whitepaper, we look at potential solutions to improve interoperability and clinical data quality while considering the pitfalls of implementation and the inevitable tradeoffs between costs and outcomes.
In this whitepaper, we examine the current landscape of healthcare and the key challenges healthcare organizations confront with cost-effectively collecting quality patient information and sharing it between stakeholders.
Enabling Compliance: High-quality data provides the foundation for improved care and quality measurement
In this whitepaper, we look at the value of clinical data curation and enrichment in terms of ensuring compliance with regulatory and certification requirements, negotiating value-based care contracts, and supporting healthcare’s new Quadruple Aim.
The demand for accurate and timely insights from a fractured and siloed health ecosystem, spanning payer, provider, and healthcare organization information infrastructures, has never been greater. New technologies and innovations have proven to be a burden on the healthcare system, including new payment models where patient outcomes are being rewarded more than the quantity of services provided. Learn more from this white paper about what you can do to solve the problem.
Transforming raw data into actionable insights is essential for Fast healthcare Interoperability Resources (FHIR) standards and improving HEDIS scores. Learn more from this roadmap on how to achieve scalable efficiencies for managing clinical data at the enterprise level. The strategic value of clinical data is growing significantly for payers, but finding the right types of clinical data and gaining access to it remain challenges in the current healthcare ecosystem.
Verinovum, Inc. recently utilized marketing partner Envision Health to execute a third-party market research study of Medicare Advantage (MA) programs in seven payer organizations of varying sizes and demographics. The goal of the study was to better understand the role and structure of MA programs within different kinds of payer organizations and how these payers and programs obtain and use clinical data for their most pressing needs.
Disease management (DM), which has been around since the 1970s and became more prevalent with the advent of managed care, was designed to improve patient quality of life. By helping to ensure continuity of care and equipping patients with education and resources to better self-manage their conditions, people with chronic disease were shown to have better outcomes than those who did not participate in disease management programs.
As value-based care takes hold, health plans and providers must collaborate more closely than ever to improve transparency and [...]